CS219950B2 - Method of making the derivatives of the n-phenoxypiperidine - Google Patents

Method of making the derivatives of the n-phenoxypiperidine Download PDF

Info

Publication number
CS219950B2
CS219950B2 CS806568A CS656880A CS219950B2 CS 219950 B2 CS219950 B2 CS 219950B2 CS 806568 A CS806568 A CS 806568A CS 656880 A CS656880 A CS 656880A CS 219950 B2 CS219950 B2 CS 219950B2
Authority
CS
Czechoslovakia
Prior art keywords
propoxy
group
radical
formula
acid
Prior art date
Application number
CS806568A
Other languages
Czech (cs)
English (en)
Inventor
Walter-Gunar Friebe
Wolfgang Kampe
Max Thiel
Wolfgang Schaumann
Otto-Henning Wilhelms
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of CS219950B2 publication Critical patent/CS219950B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CS806568A 1979-09-28 1980-09-29 Method of making the derivatives of the n-phenoxypiperidine CS219950B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792939292 DE2939292A1 (de) 1979-09-28 1979-09-28 N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
CS219950B2 true CS219950B2 (en) 1983-03-25

Family

ID=6082088

Family Applications (1)

Application Number Title Priority Date Filing Date
CS806568A CS219950B2 (en) 1979-09-28 1980-09-29 Method of making the derivatives of the n-phenoxypiperidine

Country Status (10)

Country Link
US (1) US4348401A (fr)
EP (1) EP0026876B1 (fr)
JP (1) JPS5668669A (fr)
AT (1) ATE2519T1 (fr)
CA (1) CA1139759A (fr)
CS (1) CS219950B2 (fr)
DD (1) DD153117A5 (fr)
DE (2) DE2939292A1 (fr)
ES (1) ES8105729A1 (fr)
IL (1) IL61114A0 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
HU215397B (hu) * 1994-08-29 1998-12-28 Richter Gedeon Vegyészeti Gyár Rt. (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
PL205531B1 (pl) * 2002-03-13 2010-04-30 Janssen Pharmaceutica Nv Pochodna karbonyloaminowa, jej zastosowanie i sposób wytwarzania oraz kompozycja farmaceutyczna
PL208401B1 (pl) * 2002-03-13 2011-04-29 Janssen Pharmaceutica Nv Pochodne piperazynylowe, piperydynylowe i morfolinylowe, sposób ich wytwarzania, kompozycja je zawierająca oraz ich zastosowanie
MXPA04007776A (es) 2002-03-13 2004-10-15 Janssen Pharmaceutica Nv Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa.
EP1485353B1 (fr) * 2002-03-13 2011-08-24 Janssen Pharmaceutica NV Nouveaux inhibiteurs de l'histone deacetylase
AP2336A (en) * 2004-07-28 2011-12-08 Janssen Pharmaceutica Nv Subsituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase.
RU2396955C2 (ru) * 2005-04-07 2010-08-20 Тояма Кемикал Ко., Лтд. Фармацевтическая комбинация и способ применения противогрибкового средства в комбинации
AU2006248938B2 (en) 2005-05-18 2011-09-29 Janssen Pharmaceutica N.V. Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
EP1979327A1 (fr) * 2006-01-19 2008-10-15 Janssen Pharmaceutica, N.V. Dérivés de pyridine et de pyrimidine en tant qu'inhibiteurs d'histone désacétylase
DK1981874T3 (da) * 2006-01-19 2009-09-28 Janssen Pharmactuica N V Aminophenylderivater som nye inhibitorer af histondeacetylase
EP1981875B1 (fr) * 2006-01-19 2014-04-16 Janssen Pharmaceutica N.V. Dérivés substitués d'indolyl-alkyl-amine en tant qu'inhibiteurs de l'histone désacétylase
CA2630717C (fr) 2006-01-19 2015-02-24 Janssen Pharmaceutica N.V. Derives de pyridine et de pyrimidine en tant qu'inhibiteurs d'histone desacetylase
US8604031B2 (en) 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors
KR102077864B1 (ko) 2012-08-01 2020-02-14 쇼와 덴코 패키징 가부시키가이샤 내용물 부착 방지 덮개재

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255196A (en) * 1966-06-07 Phenoxyalkyl piperidine derivatives
CH411880A (fr) * 1962-02-28 1966-04-30 Rhone Poulenc Sa Procédé de préparation de nouveaux dérivés de la pipéridine
US3691176A (en) * 1970-05-25 1972-09-12 Abbott Lab 1-(4-fluorophenoxypropyl)-4-anilino-piperidines
DE2341376A1 (de) * 1972-08-24 1974-03-07 Ciba Geigy Ag Piperidin-derivate und verfahren zu ihrer herstellung
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions
DE2737630A1 (de) * 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE3062052D1 (en) 1983-03-24
US4348401A (en) 1982-09-07
ES495412A0 (es) 1981-06-16
DD153117A5 (de) 1981-12-23
EP0026876B1 (fr) 1983-02-16
ATE2519T1 (de) 1983-03-15
ES8105729A1 (es) 1981-06-16
DE2939292A1 (de) 1981-04-09
IL61114A0 (en) 1980-11-30
JPS5668669A (en) 1981-06-09
CA1139759A (fr) 1983-01-18
EP0026876A1 (fr) 1981-04-15

Similar Documents

Publication Publication Date Title
CS219950B2 (en) Method of making the derivatives of the n-phenoxypiperidine
US5217976A (en) 1,6-naphthyridone derivatives having angiotensin ii antagonist activity
US5047404A (en) Chemical compounds
JP3120873B2 (ja) ピリジン誘導体
US5118686A (en) Phenylpyrimidones
EP0434038A1 (fr) Dérivés condensés d'imidazole, leur préparation et leur utilisation
JPH0597816A (ja) 4−アリール−チアゾール又はイミダゾール誘導体
US3482024A (en) Therapeutic treatment with 1,2-dihydro-1,2,4-benzotriazine derivatives
EP0040639A1 (fr) Derives isoxazoles
Ellis et al. Benzopyrones. 14. Synthesis and anti-allergic properties of some N-tetrazolylcarboxamides and related compounds
EP0023343B1 (fr) 3-Amino-sydnonimines substituées, procédé pour leur synthèse et préparations pharmaceutiques les contenant
US4276295A (en) 3-Aromatic moiety substituted-4(3H)-quinazolinones, process for production thereof, and use thereof
GB1566307A (en) Indole derivatives of amides and amino esters and process for their manufacture
JPS6136282A (ja) 窒素を含む複素環式化合物からなる医薬品とその製造方法
EP0089028B1 (fr) Dérivés de théophylline, et leur procédé de préparation
US4670439A (en) 2H-1-benzopyran-2-one derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US4933338A (en) Benzimidazolesulfonamides and their application as drugs
JPH0469147B2 (fr)
HU179391B (en) Process for producing thiasolo-square bracket-2,3-b-square bracket closed-quinasoline derivatives
US4082751A (en) Therapeutic agents
US4419357A (en) 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
JPH0665210A (ja) 2―フェニル複素環式化合物
DE2257443A1 (de) Neue heterocyclische verbindungen und verfahren zu deren herstellung
EP0015065B1 (fr) Dérivés de la pyrazolo (5,1-b) quinazolin-9(4H)-one, procédé pour leur préparation et compositions pharmaceutiques les contenant
US3974161A (en) Fused pyrimidin-4(3H)-ones as antiallergy agents